Recent Advances in Therapeutics for Severe Fever with Thrombocytopenia Syndrome Virus
Viruses · 2025
DOI: 10.3390/v17091174 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2025. Verfasst von Huimin Dang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Jiamusi University, Jiamusi 154007, China. Hauptthemen laut MEDLINE: Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Antiviral Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick-borne bunyavirus with a mortality rate of up to 30%. There is no specific treatment for SFTSV. This article systematically reviews the progress of major anti-SFTSV drugs. The nucleotide analogues (favipiravir, 4′-fluorouridine diphosphate prodrug VV261) have shown clinical potential. Calcium channel blockers (nifedipine, etc.) block virus invasion by inhibiting calcium influx. Monoclonal antibody (S2A5/SNB02) has achieved targeted therapy, and SNB02 nanoantibody has entered clinical trials. However, many candidate agents predominantly focus on a single target, such as viral RdRp or host calcium channels, which makes it difficult to block the entire viral replication cycle and may accelerate the accumulation of resistant mutations. In addition, the low bioavailability of small-molecule drugs, the obstacles to industrial-scale production of antibody-based therapies, and the lack of Phase III clinical evidence severely restrict their clinical translation. Future research should focus on exploring viral replication mechanisms, developing drugs against key viral proteins, and designing multi-target combination therapies and novel drug delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Jiamusi University, Jiamusi 154007, China.
- Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
ORCID-Profile: Huimin Dang, Yigang Tong
Zitieren
APA
Dang, H., Wang, Y., Zhang, L., Xu, S., Liu, L., & Tong, Y. (2025). Recent Advances in Therapeutics for Severe Fever with Thrombocytopenia Syndrome Virus. Viruses. https://doi.org/10.3390/v17091174
Vancouver
Dang H, Wang Y, Zhang L, Xu S, Liu L, Tong Y. Recent Advances in Therapeutics for Severe Fever with Thrombocytopenia Syndrome Virus. Viruses. 2025. doi:10.3390/v17091174
BibTeX
@article{Dang2025,
author = {Dang, Huimin and Wang, Yuanyuan and Zhang, Lihong and Xu, Shan and Liu, Lei and Tong, Yigang},
title = {Recent Advances in Therapeutics for Severe Fever with Thrombocytopenia Syndrome Virus},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17091174}
}
EUVIMED